AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: AMG 706 may stop the growth of cancer cells by blocking blood flow to the cancer
or by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such
as gemcitabine, work in different ways to stop the growth of cancer cells, either by killing
the cells or by stopping them from dividing. Giving AMG 706 together with gemcitabine may
kill more cancer cells.
PURPOSE: This phase I trial is studying the side effects and best dose of AMG 706 when given
together with gemcitabine in treating patients with advanced solid tumors or lymphoma.